Sarepta Therapeutics | DEBITO

Prezzo Delle Azioni
20.20
Cambio Giornaliero
-0.08 -0.39%
Mensile
-4.13%
Annuale
-83.03%
Q1 Previsione
19.71




DEBITO Cambiamento Data
Acadia Pharmaceuticals USD 56.29M 1.36M 2025-06
Agios Pharmaceuticals USD 48.76M 47.62M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amgen USD 54.59B 1.62B 2025-09
Biogen USD 6.29B 309.5M 2025-09
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Gilead Sciences USD 24.95B 6M 2025-06
Incyte USD 42.41M 5.29M 2025-06
Insmed USD 564.56M 464K 2025-09
Ionis Pharmaceuticals USD 1.23B 192.99M 2025-09
Moderna USD 741M 4M 2025-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


Sarepta Therapeutics DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.